title: The potential risks of expedited approval of drugs for acute bacterial infections.
authors.affiliation: Department of Medicine, University of Washington, Seattle.
authors.forename: James S
authors.initials: JS
authors.lastname: Floyd
authors.affiliation: Department of Medicine, University of Washington, Seattle2Department of Health Services, University of Washington, Seattle3Department of Epidemiology, University of Washington, Seattle4Group Health Research Institute, Group Health Cooperative, Seattle, Wa.
authors.forename: Bruce M
authors.initials: BM
authors.lastname: Psaty
mesh_terms: D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D024881:Drug Resistance, Bacterial; D006801:Humans; D012107:Research Design; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000900:Anti-Bacterial Agents